ICM B-Cell Lymphoma cancer trial.
July 13, 2020
ICM B-Cell Lymphoma cancer trial.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.